prikaz prve stranice dokumenta Why we should not recommend or offer fluvoxamine to COVID-19 patients?
  Download
PDF 284.41 KB
Professional paper - Letter to the editor
Why we should not recommend or offer fluvoxamine to COVID-19 patients?
European Journal of Clinical Pharmacology, 79 (2023), 2; 321-322. https://doi.org/10.1007/s00228-022-03447-3
Trkulja, Vladimir

Cite this document

Trkulja, V. (2023). Why we should not recommend or offer fluvoxamine to COVID-19 patients?. European Journal of Clinical Pharmacology, 79. (2), 321-322. doi: 10.1007/s00228-022-03447-3

Trkulja, Vladimir. "Why we should not recommend or offer fluvoxamine to COVID-19 patients?." European Journal of Clinical Pharmacology, vol. 79, no. 2, 2023, pp. 321-322. https://doi.org/10.1007/s00228-022-03447-3

Trkulja, Vladimir. "Why we should not recommend or offer fluvoxamine to COVID-19 patients?." European Journal of Clinical Pharmacology 79, no. 2 (2023): 321-322. https://doi.org/10.1007/s00228-022-03447-3

Trkulja, V. (2023) 'Why we should not recommend or offer fluvoxamine to COVID-19 patients?', European Journal of Clinical Pharmacology, 79(2), pp. 321-322. doi: 10.1007/s00228-022-03447-3

Trkulja V. Why we should not recommend or offer fluvoxamine to COVID-19 patients?. European Journal of Clinical Pharmacology [Internet]. 2023 February [cited 2024 November 07];79(2):321-322. doi: 10.1007/s00228-022-03447-3

V. Trkulja, "Why we should not recommend or offer fluvoxamine to COVID-19 patients?", European Journal of Clinical Pharmacology, vol. 79, no. 2, pp. 321-322, February 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:779915. [Accessed: 07 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Why we should not recommend or offer fluvoxamine to COVID-19 patients?
AuthorVladimir Trkulja
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Pharmacology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Basic Medical Sciences
Pharmacology
Keywords (english)
Languageenglish
Publication typeProfessional paper - Letter to the editor
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleEuropean Journal of Clinical Pharmacology
Numberingvol. 79, no. 2, pp. 321-322
p-ISSN0031-6970
e-ISSN1432-1041
DOIhttps://doi.org/10.1007/s00228-022-03447-3
URN:NBNurn:nbn:hr:105:779915
Publication2023-02
Document URLhttps://link.springer.com/10.1007/s00228-022-03447-3
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2023-05-15 11:00:51